|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 9.230 USD | -1.70% |
|
-4.05% | -49.40% |
| 08-05 | ADMA Biologics, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-05 | Tranche Update on ADMA Biologics, Inc.'s Equity Buyback Plan announced on May 7, 2025. | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADMA | Delayed | |
CBOE
| ADMA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 10.06 | 11.26 | 12.45 |
| Spread/Res. | -8.25% | -18.03% | -25.86% |
| Spread/Supp. | +9.10% | +21.45% | +15.81% |
| Support | 8.46 | 7.6 | 7.97 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADMA Stock
- Charts ADMA Biologics, Inc.
Select your edition
All financial news and data tailored to specific country editions
